Fu L Luan1, Eric Langewisch, Akinlolu Ojo. 1. Internal Medicine, Division of Nephrology, University of Michigan Taubman Center, East Medical Center Drive, Ann Arbor, MI, USA. fluan@med.umich.edu
Abstract
BACKGROUND: Metabolic syndrome (MS) and new onset diabetes after transplant (NODAT) are common in kidney transplant patients. We studied the relationship between the two conditions and their impact on metabolic and cardiovascular risk profiles. METHODS: All non-diabetic patients transplanted between 1999 and 2005 who were followed up to 2006 were included. MS and NODAT were determined. Kaplan-Meier survival and various regression analyses were performed to determine the clinical correlates for both conditions and their association with various cardiovascular risk factors. RESULTS: Among 591 patients, 314 (53.1%) had MS and 90 (15.2%) developed NODAT. The two conditions were highly associated with each other as 84 patients with NODAT also had MS (14.2%). Elevated body mass index and fasting glucose levels at transplant were risk factors for both conditions, whereas weight gain after transplant was associated only with MS. African American, old age, and hypertension-related ESRD were risk factors for NODAT. Finally, the presence of MS was associated with reduced kidney function and elevated uric acid levels, whereas the presence of NODAT with elevated pulse pressure. CONCLUSIONS: MS and NODAT are highly prevalent and significantly associated with impaired metabolic and cardiovascular risk profiles. Early identification of such conditions may facilitate targeted therapeutic intervention.
BACKGROUND:Metabolic syndrome (MS) and new onset diabetes after transplant (NODAT) are common in kidney transplantpatients. We studied the relationship between the two conditions and their impact on metabolic and cardiovascular risk profiles. METHODS: All non-diabeticpatients transplanted between 1999 and 2005 who were followed up to 2006 were included. MS and NODAT were determined. Kaplan-Meier survival and various regression analyses were performed to determine the clinical correlates for both conditions and their association with various cardiovascular risk factors. RESULTS: Among 591 patients, 314 (53.1%) had MS and 90 (15.2%) developed NODAT. The two conditions were highly associated with each other as 84 patients with NODAT also had MS (14.2%). Elevated body mass index and fasting glucose levels at transplant were risk factors for both conditions, whereas weight gain after transplant was associated only with MS. African American, old age, and hypertension-related ESRD were risk factors for NODAT. Finally, the presence of MS was associated with reduced kidney function and elevated uric acid levels, whereas the presence of NODAT with elevated pulse pressure. CONCLUSIONS: MS and NODAT are highly prevalent and significantly associated with impaired metabolic and cardiovascular risk profiles. Early identification of such conditions may facilitate targeted therapeutic intervention.
Authors: Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet Journal: Diabetes Care Date: 2003-11 Impact factor: 19.112
Authors: James B Meigs; Peter W F Wilson; David M Nathan; Ralph B D'Agostino; Ken Williams; Steven M Haffner Journal: Diabetes Date: 2003-08 Impact factor: 9.461
Authors: Yafim Brodov; Pierre Chouraqui; Ilan Goldenberg; Valentina Boyko; Lori Mandelzweig; Shlomo Behar Journal: Cardiology Date: 2009-09-23 Impact factor: 1.869
Authors: Aiko P J de Vries; Stephan J L Bakker; Willem J van Son; Jaap J Homan van der Heide; Rutger J Ploeg; Hauw T The; Paul E de Jong; Reinold O B Gans Journal: Am J Transplant Date: 2004-10 Impact factor: 8.086
Authors: Manfred Hecking; Michael Haidinger; Dominik Döller; Johannes Werzowa; Andrea Tura; Jinyao Zhang; Hilal Tekoglu; Johannes Pleiner; Thomas Wrba; Susanne Rasoul-Rockenschaub; Ferdinand Mühlbacher; Sabine Schmaldienst; Wilfred Druml; Walter H Hörl; Michael Krebs; Michael Wolzt; Giovanni Pacini; Friedrich K Port; Marcus D Säemann Journal: J Am Soc Nephrol Date: 2012-02-16 Impact factor: 10.121
Authors: Samy I McFarlane; Peter A McCullough; James R Sowers; Kyaw Soe; Shu-Cheng Chen; Suying Li; Joseph A Vassalotti; Lesley A Stevens; Moro O Salifu; Manjula Kurella Tamura; Andrew S Bomback; Keith C Norris; Allan J Collins; George L Bakris; Adam T Whaley-Connell Journal: Am J Kidney Dis Date: 2011-03 Impact factor: 8.860